Medical Equipment / Supplies / Distribution
Cellcura ASA Completes Private Placement-COMPLETE STORY
Cellcura ASA announced that it has on June 13, 2013 completed a private placement of 41,697,843 shares directed towards existing shareholders and Norwegian investors. The private placement, which represents a share capital increase of approximately 63%, was completed after the close of Oslo Stock Exchange. The subscription price was set by the board of directors at NOK 0.20 per share. The gross proceeds from the private placement will be NOK 8,339,569. The net proceeds from the private placement will be used for expenditures related to the development of the Company's projects and general corporate purposes. The private placement was managed by Magellan AS. The general meeting has resolved to conduct a subsequent offering of up to 125,000,000 new shares each with a nominal value of NOK 0.10. The subscription price will be NOK 0.20 per offer share. The subsequent offering will be directed towards the shareholders in CellCura as of close of the Oslo Stock Exchange on June 13, 2013 who did not participate in the private placement (the Eligible Shareholders). The Eligible Shareholders will be granted non-transferrable allocation rights corresponding with their pro rata ownership as per Record Date. Each allocation right gives the right to subscribe for, and be allocated, one offer share in the subsequent offering. The shares of CellCura will be traded exclusive the right to participate in the subsequent offering from and including June 14, 2013 (ex date).
Medtronic Inc Announces CE Mark of ReDuX Plier Instrument
Medtronic Inc announced the CE Mark (Conformité Européenne) and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies. With the launch of this first specially-designed surgical instrument in the spinal orthopaedic industry, physicians in the European community may now perform a more controlled osteotomy closure for people with a severe form of spinal curvature. The new instrument, called ReDuX Plier, has been developed by Medtronic European Product Development Office based in Tolochenaz, Switzerland, following an original invention by Professor Le Huec, chief of the Spine Unit and chair of the Department of Orthopaedics and Traumatology at the Bordeaux University Hospital, France.
HeartWare International Inc Announces Intention To Delist From Australian Securities Exchange
HeartWare International Inc announced that it has requested and received approval from ASX Limited for its removal from the official list of ASX. Trading in HeartWare's CHESS Depositary Interests (CDIs) will be suspended on ASX at the close of market on September 10, 2013. HeartWare's shares of common stock are currently listed for trading on the NASDAQ Global Select Market under the symbol HTWR and HeartWare’s CDIs are traded on the ASX under the code HIN. One share of HeartWare common stock is equivalent to 35 CDIs. ASX has advised that in accordance with the Company's request, it will remove the Company from the official list of ASX with effect from the close of trading on September 17, 2013 subject to HeartWare providing a voluntary sale facility through which holders of CDIs may sell their shares of common stock on NASDAQ (as described below) and notifying CDI holders of the availability of the sale facility. HeartWare's common stock will continue to be listed on NASDAQ.
Visiomed Group SA's Tag Replay Electronic Inhaler Registered with ANSM
Visiomed Group SA announced that its Tag Replay electronic inhaler has been registered with the ANSM (Agence nationale de securite du medicament et des produits de sante).
RTI Biologics Inc Announces Agreement To Acquire Pioneer Surgical Technology
RTI Biologics Inc announced that its intent to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich. Pioneer is a medical technology company that manufactures and distributes metal and synthetic products in the orthopedics, biologics, spine, trauma and cardiothoracic markets. Under the terms of the merger agreement, RTI will pay $130 million in cash to acquire all the outstanding stock of Pioneer. The transaction will be funded through a combination of cash on hand, a new credit facility and a concurrent private placement of convertible preferred equity from Water Street Healthcare Partners. Additionally, RTI has agreed to a $50 million private placement of convertible preferred equity with Water Street, a healthcare-focused private equity firm with operating experience and industry knowledge.
NIPRO CORP Announces Outcome of Tender Offer to Repurchase Shares
NIPRO CORP announced that the tender offer to repurchase shares was completed on June 11, 2013. 19,834,000 shares of its common stock (a 11.57% stake) where accepted in the tender offer, at the price of JPY 862 per share, or for JPY 17,096,908,000 in total, during the period from May 15, 2013 to June 11, 2013.
St. Jude Medical Inc Announces FDA Approval of High-Voltage Devices with New Safety Features
St. Jude Medical Inc announced U.S. Food and Drug Administration (FDA) approval of its Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery. The Ellipse and SJM Assura family of devices feature the DynamicTx Over-Current Detection Algorithm, which automatically adjusts shocking configurations to ensure the delivery of high-voltage therapy even if an electrical short in one portion of the system were to occur. In addition, the Ellipse and SJM Assura portfolio of implantable defibrillators have a low-friction coating on the device can, which has been demonstrated in testing to significantly reduce the friction between the device and leads. As such, the low-friction coating provides an extra layer of insulation and is designed to reduce the risk for lead-to-can abrasion, the most common type of lead insulation failure in the industry.
China Healthcare Holdings Ltd Announces Change Of Auditors
China Healthcare Holdings Ltd announced that China Zenith CPA Limited (Zenith) have resigned as the auditors of the Company and its subsidiaries (collectively, the Group) with effect from June 11, 2013 as Zenith have not received certain information necessary for them to complete their audit procedures from the Group within the agreed timeframe. Taking into account their available internal resources in light of their current workflows and in order not to put the Group at risk of not being able to release its financial results for the year ended March 31, 2013 on or before June 30, 2013, after due consideration, Zenith tendered its resignation as auditors of the Group. The Board resolved to appoint Elite Partners CPA Limited as the auditors of the Group to fill the casual vacancy arising from the resignation of Zenith and to hold office until the conclusion of the next annual general meeting of the Company.
Stille AB Divests Sonesta to ADDvise Lab Solutions AB
Stille AB announced that on June 10, 2013, it has entered into an agreement to sell Sonesta to ADDvise Lab Solutions AB. The take-over is to take place on September 2, 2013. The price amounts to SEK 21 million in total, of which SEK 6 million is to be paid in cash on take-over date, SEK 6 million in newly issued ADDvise shares as well as SEK 9 million to be paid without conditions in three stages until 2016.
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  -0.11% |
| Basic Materials |  +0.19% |
| Industrials | +0.20% |
| Cyclical Goods & Services | +0.32% |
| Non-Cyclical Goods & Services | +0.36% |
| Financials | -0.05% |
| Healthcare | +0.06% |
| Technology | -0.07% |
| Telecoms | -0.15% |
| Utilities | -0.24% |
| DOW | 15,300.53 | -17.70 |
-0.12% |
| S&P 500 | 1,649.92 | -1.89 |
-0.11% |
| NASDAQ | 3,474.30 | -7.88 |
-0.23% |
| TR US Index | 149.55 | -0.25 |
-0.16% |
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
